Tap these key trends for big returns

Article Excerpt

Alcon offers investors two exciting ways to profit. Not only does it give you exposure to rapidly expanding, worldwide demand for its contact lenses and cataract surgery products, but its global operations and technological leadership enhance the possibility of it attracting a lucrative takeover bid. That could come from a rival or a global health-care giant. Swiss pharmaceutical giant Novartis spun off Alcon just last year. And as we’ve said many times before, spinoffs are the closest thing you can find to a sure thing, regardless of market ups and downs. We believe trends now underway—including Alcon’s strong position in its key markets—have set its sales, profit and share price on a strong growth path. We recommend this stock as a Power Buy. ALCON INC. $63.26 (New York symbol ALC; TSINetwork Rating: Extra Risk) (www.alcon.com; Shares o/s: 491.7 million; Market cap: $31.1 billion; No divds.) is the world’s biggest eye-care company. Specifically, it’s the leader in ocular surgical supplies and No. 2 in contact lenses. While Alcon is…